Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02742246 · ClinicalTrials.gov registry record · NA
Efficacy and Mechanisms of CBT4CBT for Alcohol Use Disorders
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 99
- Enrollment target
NCT02742246: Completed NA study, sponsored by Yale University.
NCT02742246 is a NA study that has completed, run by Yale University. The registered enrollment target is 99 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02742246, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 99 participants
- Enrollment target
Study Summary
Evaluate the efficacy of CBT4CBT and clinician-delivered CBT relative to standard treatment for reducing alcohol use
Primary Outcome
The Timeline Follow Back is a calendar-based questionnaire used to assess alcohol use-consumption variables and can be used to measure alcohol use over time. This outcome was updated upon results entry. Presented are the percent days abstinent from alcohol use.
Interventions
- BEHAVIORAL Individual clinician-provided CBT
- BEHAVIORAL CBT4CBT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 99 participants |
| Start Date | 2017-02-14 |
| Est. Completion | 2021-12-31 |
| Phase | NA |
What the finished NCT02742246 record still lists
NCT02742246 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 99 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 2 interventions - of which Individual clinician-provided CBT is the first listed.
NCT02742246 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02742246 about?
NCT02742246 is a clinical study titled "Efficacy and Mechanisms of CBT4CBT for Alcohol Use Disorders". Evaluate the efficacy of CBT4CBT and clinician-delivered CBT relative to standard treatment for reducing alcohol use
What is the current status of trial NCT02742246?
This trial is currently completed. It is a NA study. The enrollment target is 99 participants. The study started on 2017-02-14. Estimated completion is 2021-12-31.
What interventions are being tested in trial NCT02742246?
The interventions under investigation include: Individual clinician-provided CBT (BEHAVIORAL), CBT4CBT (BEHAVIORAL).
Who is sponsoring clinical trial NCT02742246?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02742246's enrollment target sits among peer trials
99 920th of 2000 higher than 1,079 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03965234 · 99 participants · Phase 1
Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal Metastases
- NCT04022616 · 99 participants
Myeloid-Derived Suppressor Cell Function in Breast Cancer Patients
- NCT04042844 · 99 participants · Phase 2
A Single Dose of BRTX 100 for Patients With Chronic Lumbar Disc Disease (cLDD)
- NCT04143724 · 99 participants · Phase 2
Study of Safety & PK of Luspatercept (ACE-536) in Pediatric Participants With Beta (β)-Thalassemia
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI